missing translation for 'onlineSavingsMsg'
Learn More

CD3 Mouse anti-Human , BV421, Clone: OKT3, BD Biosciences™

Mouse Monoclonal Antibody

208.00€ - 473.00€

Specifications

Antigen CD3
Clone OKT3
Applications Flow Cytometry
Classification Monoclonal
Conjugate Brilliant Violet 421
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17207544
View Documents
BD Biosciences
566697
25 Tests
208.00€
25 tests
Estimated Shipment: 04-02-2025
to see stock.
Add to basket
 
17297534
View Documents
BD Biosciences
566696
100 Tests
473.00€
100 tests
Estimated Shipment: 04-02-2025
to see stock.
Add to basket
 
Description

Description

CD3 Monoclonal antibody specifically detects CD3 in Human samples. It is validated for Flow Cytometry
Specifications

Specifications

CD3
Flow Cytometry
Brilliant Violet 421
RUO
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Sheep Erythrocyte Rosette-purified Human T Cells
Primary
OKT3
Monoclonal
Mouse
Human
CD3E; CD3e; T-cell surface antigen T3/Leu-4 epsilon; T3E; TCRE
IgG2a κ
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BV421 under optimum conditions, and unconjugated antibody and free BD Horizon BV421 were removed.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.